24/7 Customer Support

Talk to Clare

+1 339 368 6001

Publication dates

Gene Therapy Industry, October 2014 Market Reports from Top Publishers

You might be interested in: Hemophilia, Cancer, Medical Equipment, more »


 
1-10 of 33 reports for Gene Therapy

Global Gene Therapy Market Outlook 2018

Global Gene Therapy Market Outlook 2018

  • $ 1 500
  • Industry report
  • September 2014
  • by RNCOS

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the ...

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... In the fields of regenerative medicine and gene therapy. The company provides therapies for autologous and heterologous transplants. Molmed is headquartered in milano, italy.Molmed s.P.A. Key recent ...

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... therapy to treat lysosomal storage diseases that affect the cnsoct 31, 2013: fidelity biosciences and regenx biosciences launch dimension therapeutics to develop and commercialize novel aav gene therapy ...

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Biotechnology research reagents and equipment. It operates through three business divisions, such as bio-industry, gene therapy, and agribio. Its bio-industry division offers sale of a gene amplification system ...

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... On umbilical cord blood, which is used in acquired hearing loss, early childhood brain damage, aplastic anemia, blood cancer, solid tumors, type 1 diabetes, and gene therapy for severe immune deficiency ...

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... To the patient. The company has a strategic collaboration with celgene corporation to discover, develop and commercialize disease-altering gene therapy products in oncology. Genetix is headquartered in cambridge ...

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...

Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...

Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Cell culturecell therapyclinical testingdevicesdiagnosticsdiscovery toolsdrug deliveryenabling technologyequipmentfacilitiesgene therapy ...

About 400 reports for Gene Therapy

Download Unlimited Documents from Trusted Public Sources

Takara Bio Annual Report 2014

  • Annual Report
  • January 2014
    38 pages
  • Japan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.